Dong, W., Lei, P., Liu, X., Li, Q., & Cheng, X. (2021). Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Dong, Wen, Pengfei Lei, Xin Liu, Qin Li, et Xiangyang Cheng. Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Dong, Wen, et al. Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma. Frontiers Media S.A, 2021.